Wegovy Becomes First GLP-1 Inhibitor To Win English Funding For Preventing Heart Attacks And Strokes

Doctor drawing ECG heartbeat chart with marker on whiteboard
NICE has recommended Wegovy for reducing the risk of major adverse cardiovascular events (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from HTA

More from Market Access